AtriCure (ATRC) to Acquire nContact in Cash, Stock Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Canaccord Genuity Cuts Price Target on AtriCure (ATRC) on Current Weakness
October 6, 2015 8:55 AM EDTCanaccord Genuity maintained a Buy rating on AtriCure Inc. (NASDAQ: ATRC), and cut the price target to $28.00 (from $31.00), on current weakness. Analyst Jason Mills recommend investors add to positions in ATRC on weakness associated with the nContact deal.
Mills Commented, "We recommend investors add to positions in ATRC on weakness associated with the nContact deal. We believe this business combination will 1) strengthen AtriCures presence in the AF market; 2) expand its... More
